Enantiomeric separation and quantification of citalopram in serum by ultra-high performance supercritical fluid chromatography-tandem mass spectrometry
- 1 September 2017
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1061-1062, 103-109
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Preparative supercritical fluid chromatography: A powerful tool for chiral separationsJournal of Chromatography A, 2016
- Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicologyJournal of Chromatography A, 2012
- Supercritical fluid chromatography for the enantioseparation of pharmaceuticalsJournal of Pharmaceutical and Biomedical Analysis, 2012
- PharmGKB summaryPharmacogenetics and Genomics, 2011
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011Pharmacopsychiatry, 2011
- Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolitesBiomedical Chromatography, 2010
- Stereoisomer analysis of wastewater-derived β-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography–tandem mass spectrometryJournal of Chromatography A, 2007
- Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC‐MS/MS: Application to pharmacokineticsChirality, 2007
- Peer Reviewed: SFC of Drug Enantiomers.Analytical Chemistry, 2000
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal of Neural Transmission, 1992